Clinique Rive Gauche
- Address
- 49 Allées Charles de Fitte, 31300 Toulouse, France
Clinique Rive Gauche - Retinal Disease Research Center
Clinique Rive Gauche is a specialized medical research center dedicated to advancing treatments for rare and complex retinal disorders. The center demonstrates particular expertise in investigating innovative therapeutic approaches for conditions affecting retinal vasculature and vision preservation.
- Coats' disease and retinal vascular abnormalities
- Anti-VEGF intravitreal injection therapies
- Comparative effectiveness of laser photocoagulation versus biological treatments
The center conducts multicenter randomized controlled trials evaluating intravitreal anti-VEGF injections as both initial and adjuvant treatment modalities. Their research focuses on optimizing treatment protocols for Coats' disease, a rare retinal condition characterized by abnormal vascular development, by comparing novel biological therapies with established laser photocoagulation techniques to determine the most effective interventions for disease stage management.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Clinique Rive Gauche
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy of Intravitreal Bevacizumab as Initial and Adjuvant Therapy in Coats' Disease: A Multicenter Randomized Controlled Trial | Fondation A De Rothschild | Phase II | Not Recruiting | Nov 2024 | Jan 2026 |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Bevacizumab | 1 | Unknown | 2024-11-06 | 2024-11-06 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.